These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25783795)

  • 1. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.
    Hoffmann VS; Baccarani M; Hasford J; Lindoerfer D; Burgstaller S; Sertic D; Costeas P; Mayer J; Indrak K; Everaus H; Koskenvesa P; Guilhot J; Schubert-Fritschle G; Castagnetti F; Di Raimondo F; Lejniece S; Griskevicius L; Thielen N; Sacha T; Hellmann A; Turkina AG; Zaritskey A; Bogdanovic A; Sninska Z; Zupan I; Steegmann JL; Simonsson B; Clark RE; Covelli A; Guidi G; Hehlmann R
    Leukemia; 2015 Jun; 29(6):1336-43. PubMed ID: 25783795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.
    Hoffmann VS; Baccarani M; Hasford J; Castagnetti F; Di Raimondo F; Casado LF; Turkina A; Zackova D; Ossenkoppele G; Zaritskey A; Höglund M; Simonsson B; Indrak K; Sninska Z; Sacha T; Clark R; Bogdanovic A; Hellmann A; Griskevicius L; Schubert-Fritschle G; Sertic D; Guilhot J; Lejniece S; Zupan I; Burgstaller S; Koskenvesa P; Everaus H; Costeas P; Lindoerfer D; Rosti G; Saussele S; Hochhaus A; Hehlmann R
    Leukemia; 2017 Mar; 31(3):593-601. PubMed ID: 27568522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate.
    Uz B; Buyukasik Y; Atay H; Kelkitli E; Turgut M; Bektas O; Eliacik E; Isik A; Aksu S; Goker H; Sayinalp N; Ozcebe OI; Haznedaroglu IC
    Hematology; 2013 Sep; 18(5):247-52. PubMed ID: 23540886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of Sokal, Hasford and EUTOS prognostic scoring systems in chronic myeloid leukemia].
    Feng G; Wang J; Jiang Y; Li Y; Ding M; Wang N; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):743-6. PubMed ID: 25152126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?
    Gurrea Salas D; Glauche I; Tauer JT; Thiede C; Suttorp M
    Ann Hematol; 2015 Aug; 94(8):1363-71. PubMed ID: 25894600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.
    Höglund M; Sandin F; Hellström K; Björeman M; Björkholm M; Brune M; Dreimane A; Ekblom M; Lehmann S; Ljungman P; Malm C; Markevärn B; Myhr-Eriksson K; Ohm L; Olsson-Strömberg U; Själander A; Wadenvik H; Simonsson B; Stenke L; Richter J
    Blood; 2013 Aug; 122(7):1284-92. PubMed ID: 23843494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
    Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
    Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.
    Millot F; Guilhot J; Suttorp M; Güneş AM; Sedlacek P; De Bont E; Li CK; Kalwak K; Lausen B; Culic S; Dworzak M; Kaiserova E; De Moerloose B; Roula F; Biondi A; Baruchel A
    Haematologica; 2017 Oct; 102(10):1704-1708. PubMed ID: 28838993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
    Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
    BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia.
    Pfirrmann M; Baccarani M; Saussele S; Guilhot J; Cervantes F; Ossenkoppele G; Hoffmann VS; Castagnetti F; Hasford J; Hehlmann R; Simonsson B
    Leukemia; 2016 Jan; 30(1):48-56. PubMed ID: 26416462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.
    Faye BF; Dieng N; Seck M; Gadji M; Gueye YB; Sy D; Toure SA; Sall A; Toure AO; Dieye TN; Diop S
    Ann Hematol; 2016 Oct; 95(10):1603-10. PubMed ID: 27370991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
    Kulikov SM; Vinogradova OIu; Chelysheva EIu; Tishchenko IA; Galaĭko MA; Lazareva OV; Senderova OM; Pepeliaeva VM; Meresiĭ SV; Luchinin AS; Ovsepian VA; Miliutina GI; Gavrilova LV; Avdeeva LB; Neverova AL; Turkina AG
    Ter Arkh; 2014; 86(7):24-30. PubMed ID: 25314774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Early Molecular Response in Chronic Myeloid Leukemia.
    Chikkodi SV; Malhotra P; Naseem S; Khadwal A; Prakash G; Sahu KK; Kumari S; Suri V; Varma N; Varma S
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S114-9. PubMed ID: 26297263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
    Iriyama N; Fujisawa S; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
    Am J Hematol; 2015 Apr; 90(4):282-7. PubMed ID: 25530131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Descriptive epidemiology of myeloid leukemia].
    Matsuo K; Ito H
    Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
    Pfirrmann M; Clark RE; Prejzner W; Lauseker M; Baccarani M; Saussele S; Guilhot F; Heibl S; Hehlmann R; Faber E; Turkina A; Ossenkoppele G; Höglund M; Zaritskey A; Griskevicius L; Olsson-Strömberg U; Everaus H; Koskenvesa P; Labar B; Sacha T; Zackova D; Cervantes F; Colita A; Zupan I; Bogdanovic A; Castagnetti F; Guilhot J; Hasford J; Hochhaus A; Hoffmann VS
    Leukemia; 2020 Aug; 34(8):2138-2149. PubMed ID: 32601376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia.
    Iriyama N; Hatta Y; Kobayashi S; Uchino Y; Miura K; Kurita D; Kodaira H; Inoue M; Takei M
    Int J Hematol; 2014 Oct; 100(4):379-85. PubMed ID: 25092482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myeloid leukemia--from the National to the European Registry--limited experience of a single center.
    Vlădăreanu AM; Voican I; Bumbea H; Vasile D; Radesi S; Coriu D; Coliţa A; Tălmaci R; Ilea A
    Rom J Intern Med; 2010; 48(1):73-9. PubMed ID: 21180244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.
    Bonifazi F; De Vivo A; Rosti G; Tiribelli M; Russo D; Trabacchi E; Fiacchini M; Montefusco E; Baccarani M
    Br J Haematol; 2000 Nov; 111(2):587-95. PubMed ID: 11122107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib.
    Chhikara S; Sazawal S; Singh K; Chaubey R; Pati H; Tyagi S; Mahapatra M; Saxena R
    South Asian J Cancer; 2018; 7(4):258-262. PubMed ID: 30430096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.